Sarilumab 150 mg in 1.14 mL Auto-Injector
RxNorm 2003755
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2003755 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: sarilumab 150 mg in 1.14 mL Auto-Injector.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
1.14 mL sarilumab 132 mg/ML Auto-Injector
(Atom ID: 9836827)
PSNPrescribable
Prescribable Name (PSN):
Sarilumab 150 mg in 1.14 mL Auto-Injector
(Atom ID: 9836836)
SYPrescribable
Synonym (SY):
Sarilumab 150 mg per 1.14 mL Auto-Injector
(Atom ID: 9836837)
Patient Education
Sarilumab Injection
Sarilumab injection is used alone or with other medications to treat rheumatoid arthritis (RA: condition in which the body attacks its own joints causing pain, swelling, and loss of function). Sarilumab is usually used by people who were not helped by certain other drugs for RA or who could not take these medications. Sarilumab injection is in a class of medications called interleukin-6 (IL-6) receptor inhibitors. It works by blocking the activity of interleukin-6, a substance in the body that causes inflammation.
[Learn More]
* Please review the disclaimer below.